NCT06200311View on ClinicalTrials.gov

Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men

NARecruitingINTERVENTIONAL
Enrollment

604

Participants

Timeline

Start Date

July 25, 2024

Primary Completion Date

July 25, 2029

Study Completion Date

July 25, 2029

Conditions
Fibrillation, AtrialAtrial Cardiomyopathy
Interventions
PROCEDURE

Pulmonary vein isolation

Pulmonary vein isolation using pulsed field ablation (PFA), cryoballoon or radiofrequency ablation (RFA)

DRUG

Pharmacological rhythm management

1st line: rate control, 2nd line: pharmacological rhythm management. 3rd line: AF ablation

Trial Locations (1)

9715BS

RECRUITING

UMCG, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER